The impact of community-based, peer-led sexual and reproductive health services on knowledge of HIV status among adolescents and young people aged 15 to 24 in Lusaka, Zambia: The Yathu Yathu cluster-randomised trial.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
04 2023
Historique:
received: 19 07 2022
accepted: 20 02 2023
medline: 25 4 2023
pubmed: 21 4 2023
entrez: 21 04 2023
Statut: epublish

Résumé

The growing population of adolescents and young people (AYP) aged 15 to 24 in sub-Saharan Africa face a high burden of HIV in many settings. Unintended pregnancies among adolescent girls in the region remain high. Nonetheless, the sexual and reproductive health (SRH) service needs of AYP have remained underserved. We conducted a cluster-randomised trial (CRT) to estimate the impact of community-based, peer-led SRH service provision on knowledge of HIV status and other SRH outcomes, including met need for contraceptives. Yathu Yathu was a cluster-randomised trial (CRT) conducted from 2019 to 2021 in 2 urban communities in Lusaka, Zambia. The communities were divided into 20 zones (approximately 2,350 AYP/zone) that were randomly allocated to the Yathu Yathu intervention or control arm. In each intervention zone, a community-based hub, staffed by peer support workers, was established to provide SRH services. In 2019, a census was conducted in all zones; all consenting AYP aged 15 to 24 were given a Yathu Yathu card, which allowed them to accrue points for accessing SRH services at the hub and health facility (intervention arm) or the health facility only (control arm). Points could be exchanged for rewards, thus acting as an incentive to use SRH services in both arms. We conducted a cross-sectional survey in 2021 to estimate the impact of Yathu Yathu on the primary outcome: knowledge of HIV status (self-reporting living with HIV or HIV testing in the last 12 months) and secondary outcomes, including use of pre-exposure prophylaxis (PrEP) in the last 12 months, current use of antiretroviral therapy (ART), and met need for contraceptive services. The sampling was stratified on sex and age group, and we analysed data at cluster-level using a two-stage process recommended for CRTs with <15 clusters/arm. A total of 1,989 AYP consented to participate in the survey (50% male); consent was similar across arms (63% consent/arm). Across zones, knowledge of HIV status ranged from 63.6% to 81.2% in intervention zones and 35.4% to 63.0% in control zones. Adjusting for age, sex, and community, knowledge of HIV status was higher in the intervention arm compared to control (73.3% versus 48.4%, respectively, adjusted prevalence ratio (PR) 1.53 95% CI 1.36, 1.72; p < 0.001). By age and sex, results were similar. There was no evidence for impact on any secondary outcomes, including current use of ART and met need for contraceptives. There were no adverse events reported in either arm. A key limitation of our trial is that approximately 35% of the AYP randomly selected for participation in the endline survey could not be reached. Delivering community-based, peer-led SRH services increased knowledge of HIV status among AYP, both males and females, compared with the control arm. Scaling up the highly effective Yathu Yathu strategy has the potential to make a substantial contribution to increasing access to HIV prevention and care services for young people. However, additional implementation research is needed to understand how to improve uptake of broader SRH services, beyond uptake of HIV testing. ISRCTN75609016, clinicaltrials.gov number NCT04060420.

Sections du résumé

BACKGROUND
The growing population of adolescents and young people (AYP) aged 15 to 24 in sub-Saharan Africa face a high burden of HIV in many settings. Unintended pregnancies among adolescent girls in the region remain high. Nonetheless, the sexual and reproductive health (SRH) service needs of AYP have remained underserved. We conducted a cluster-randomised trial (CRT) to estimate the impact of community-based, peer-led SRH service provision on knowledge of HIV status and other SRH outcomes, including met need for contraceptives.
METHODS AND FINDINGS
Yathu Yathu was a cluster-randomised trial (CRT) conducted from 2019 to 2021 in 2 urban communities in Lusaka, Zambia. The communities were divided into 20 zones (approximately 2,350 AYP/zone) that were randomly allocated to the Yathu Yathu intervention or control arm. In each intervention zone, a community-based hub, staffed by peer support workers, was established to provide SRH services. In 2019, a census was conducted in all zones; all consenting AYP aged 15 to 24 were given a Yathu Yathu card, which allowed them to accrue points for accessing SRH services at the hub and health facility (intervention arm) or the health facility only (control arm). Points could be exchanged for rewards, thus acting as an incentive to use SRH services in both arms. We conducted a cross-sectional survey in 2021 to estimate the impact of Yathu Yathu on the primary outcome: knowledge of HIV status (self-reporting living with HIV or HIV testing in the last 12 months) and secondary outcomes, including use of pre-exposure prophylaxis (PrEP) in the last 12 months, current use of antiretroviral therapy (ART), and met need for contraceptive services. The sampling was stratified on sex and age group, and we analysed data at cluster-level using a two-stage process recommended for CRTs with <15 clusters/arm. A total of 1,989 AYP consented to participate in the survey (50% male); consent was similar across arms (63% consent/arm). Across zones, knowledge of HIV status ranged from 63.6% to 81.2% in intervention zones and 35.4% to 63.0% in control zones. Adjusting for age, sex, and community, knowledge of HIV status was higher in the intervention arm compared to control (73.3% versus 48.4%, respectively, adjusted prevalence ratio (PR) 1.53 95% CI 1.36, 1.72; p < 0.001). By age and sex, results were similar. There was no evidence for impact on any secondary outcomes, including current use of ART and met need for contraceptives. There were no adverse events reported in either arm. A key limitation of our trial is that approximately 35% of the AYP randomly selected for participation in the endline survey could not be reached.
CONCLUSIONS
Delivering community-based, peer-led SRH services increased knowledge of HIV status among AYP, both males and females, compared with the control arm. Scaling up the highly effective Yathu Yathu strategy has the potential to make a substantial contribution to increasing access to HIV prevention and care services for young people. However, additional implementation research is needed to understand how to improve uptake of broader SRH services, beyond uptake of HIV testing.
TRIAL REGISTRATION
ISRCTN75609016, clinicaltrials.gov number NCT04060420.

Identifiants

pubmed: 37083700
doi: 10.1371/journal.pmed.1004203
pii: PMEDICINE-D-22-02482
pmc: PMC10121029
doi:

Substances chimiques

Contraceptive Agents 0

Banques de données

ClinicalTrials.gov
['NCT04060420']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1004203

Subventions

Organisme : Medical Research Council
ID : MR/R022216/1
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Hensen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Int AIDS Soc. 2021 Feb;24(2):e25666
pubmed: 33569913
AIDS Behav. 2022 Jan;26(1):172-182
pubmed: 34302282
AIDS. 2010 Oct 23;24(16):2541-52
pubmed: 20881473
BMC Public Health. 2016 Oct 10;16(1):1069
pubmed: 27724886
Int J Gynaecol Obstet. 2010 Jul;110 Suppl:S3-6
pubmed: 20451907
J Int AIDS Soc. 2017 May 16;20(Suppl 3):21528
pubmed: 28530039
Afr J AIDS Res. 2021 Dec;20(4):314-323
pubmed: 34905454
Reprod Health. 2014 Jan 02;11(1):1
pubmed: 24383405
Reprod Health. 2021 Jun 27;18(1):135
pubmed: 34176511
N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
Contemp Clin Trials. 2021 Nov;110:106568
pubmed: 34543725
AIDS Behav. 2017 Jul;21(7):2156-2166
pubmed: 27544516
BMC Health Serv Res. 2021 Jul 29;21(1):753
pubmed: 34325696
Int J Epidemiol. 2002 Aug;31(4):839-46
pubmed: 12177032
Afr J AIDS Res. 2020 Mar;19(1):13-23
pubmed: 32174231
J Epidemiol Community Health. 2022 Feb;76(2):158-167
pubmed: 34518330
Afr J Reprod Health. 2019 Jun;23(2):134-147
pubmed: 31433601
BMC Public Health. 2021 Jun 26;21(1):1228
pubmed: 34172027
N Engl J Med. 2021 Aug 12;385(7):595-608
pubmed: 34379922
BMC Health Serv Res. 2022 Apr 14;22(1):503
pubmed: 35421966
J Acquir Immune Defic Syndr. 2021 Sep 1;88(1):45-56
pubmed: 34050101
Trop Med Int Health. 2011 Jul;16(7):828-9
pubmed: 21418449
PLoS One. 2018 Aug 10;13(8):e0197904
pubmed: 30096139
Glob Public Health. 2022 Aug;17(8):1652-1664
pubmed: 34193012
MMWR Morb Mortal Wkly Rep. 2014 Nov 28;63(47):1097-103
pubmed: 25426651
Lancet HIV. 2019 Feb;6(2):e137-e140
pubmed: 30660592
BMC Public Health. 2021 Apr 14;21(1):727
pubmed: 33853575
AIDS. 2017 Jul 01;31 Suppl 3:S221-S232
pubmed: 28665880
J Adolesc Health. 2021 Apr;68(4):719-727
pubmed: 33059959
J Adolesc Health. 2012 Aug;51(2):106-21
pubmed: 22824440
Afr J AIDS Res. 2021 Mar;20(1):6-14
pubmed: 33685378
J Int AIDS Soc. 2020 Jun;23 Suppl 3:e25537
pubmed: 32602658
J Adolesc Health. 2010 Nov;47(5):512-22
pubmed: 20970087
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):458-466
pubmed: 30085953
PLoS One. 2021 Feb 4;16(2):e0246308
pubmed: 33539394
BMJ Glob Health. 2021 Jul;6(Suppl 4):
pubmed: 34275877
AIDS Behav. 2020 Oct;24(10):2797-2810
pubmed: 32152815
AIDS. 2021 Feb 2;35(2):275-285
pubmed: 33048875
J Health Commun. 2008 Jun;13(4):345-56
pubmed: 18569365
BMJ. 2004 Mar 20;328(7441):702-8
pubmed: 15031246
Trop Med Int Health. 2022 Jan;27(1):2-12
pubmed: 34861086
Stat Med. 1996 Jun 15;15(11):1069-92
pubmed: 8804140

Auteurs

Bernadette Hensen (B)

Department of Public Health, the Institute of Tropical Medicine, Antwerp, Belgium.
Department of Clinical Research, the London School of Hygiene and Tropical Medicine, London, United Kingdom.

Sian Floyd (S)

Department of Infectious Disease Epidemiology, the London School of Hygiene and Tropical Medicine, London, United Kingdom.

Ab Schaap (A)

Department of Infectious Disease Epidemiology, the London School of Hygiene and Tropical Medicine, London, United Kingdom.
Zambart, Lusaka, Zambia.

Lucheka Sigande (L)

Zambart, Lusaka, Zambia.

Melvin Simuyaba (M)

Zambart, Lusaka, Zambia.

Lawrence Mwenge (L)

Zambart, Lusaka, Zambia.

Rosemary Zulu-Phiri (R)

Zambart, Lusaka, Zambia.

Louis Mwape (L)

Zambart, Lusaka, Zambia.

Sarah Fidler (S)

Department of Infectious Disease, Imperial College London, United Kingdom.

Richard Hayes (R)

Department of Infectious Disease Epidemiology, the London School of Hygiene and Tropical Medicine, London, United Kingdom.

Helen Ayles (H)

Department of Clinical Research, the London School of Hygiene and Tropical Medicine, London, United Kingdom.
Zambart, Lusaka, Zambia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH